Article Information
History
- April 26, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Amber Kunkel1,2,*,
- Seonghye Jeon3,
- Haim C Joseph4,
- Pierre Dilius4,
- Kelly Crowdis5,
- Martin I. Meltzer3 and
- Ryan Wallace1
- 1Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
- 2Epidemic Intelligence Service, Center for Surveillance, Epidemiology and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
- 3Emergency Preparedness and Response Branch, Division of Preparedness and Emerging Infections, National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
- 4Ministry of Agriculture, Rural Development, and Natural Resources, Port-au-Prince, Haiti
- 5Christian Veterinary Mission, Port-au-Prince, Haiti
- ↵*Corresponding author; akunkel{at}cdc.gov
Posted April 26, 2021.
The urgency of resuming disrupted dog rabies vaccination campaigns: a modeling and cost-effectiveness analysis
